| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), KPRX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.7K | $118.3K | - | |
| Other | 31.7K | $61.9K | - | |
| CFO | 27.0K | $52.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2017 | Ventech Capital II | 10% Owner | Sell | 4,419 | $2.80 | $12,384.69 | -0.3% | |
| Mar 6, 2017 | Goldberg Morton | Director | Sell | 8,919 | $3.00 | $26,757.00 | -48.6% | |
| Sep 15, 2016 | From Stephen | President and CEO | Buy | 15,000 | $1.49 | $22,338.00 | +12.0% | |
| Jun 15, 2016 | Goldberg Morton | Director | Sell | 15,000 | $3.16 | $47,361.00 | -46.5% | |
| Jun 10, 2016 | Ventech Capital II | 10% Owner | Sell | 28,600 | $3.04 | $86,855.71 | -1.8% | |
| Jun 8, 2016 | Ventech Capital II | 10% Owner | Sell | 29,400 | $3.25 | $95,423.60 | -1.8% | |
| Jun 7, 2016 | Goldberg Morton | Director | Sale+OE | 10,939 | $3.31 | $36,203.29 | -25.3% | |
| Feb 19, 2015 | Chaney Paul G | Director | Buy | 8,333 | $6.00 | $49,998.00 | New | |
| Feb 19, 2015 | Ipsa (innoven Partenaires S.a.) | 10% Owner | Buy | 366,667 | $6.00 | $2,200,002.00 | +33.5% |